Avenue Biosciences Holding Inc — Form D
Avenue Biosciences Holding Inc of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-28. The offering totals $8.4M, of which $7.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-28
- Form: D
- Accession: 0002101752-26-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $8.4M
- Amount sold: $7.4M
- Remaining: $917K
- Investors: 12
- Date of first sale: 2025-11-20
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-571363
Issuer
- Name: Avenue Biosciences Holding Inc
- CIK: 0002101752
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 211 LAUREL STREET, MENLO PARK, CA, 94025
- Phone: 6502858564
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Tero-Pekka Alastalo | Director | Menlo Park, CA |
| Jenny Engerfelt | Director | Borensberg, V7 |
| Gabriel Poteliunaite | Director | Gdansk, R9 |
| Katja Rosti | Director | Helsinki, H9 |
| Tero-Pekka Alastalo | Executive Officer | Menlo Park, CA |
| Katja Rosti | Executive Officer | Helsinki, H9 |
More